Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/1/2020
SIETES contiene 92882 citas

 
 
 1 a 20 de 70 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Manson JE, Cook NR, Lee I-M, Christen W, Bassuk SS, Gibson H, Albert CM, Gordon D, Copeland T, D'Agostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE, for the VITAL Research Group. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. N Engl J Med 2019;380:3 de enero. [Ref.ID 102995]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
The ASCEND Study Collaborative Group. Effects of n-3 fatty acid supplements in diabetes mellitus. N Engl J Med 2018;379:18 de octubre. [Ref.ID 102845]
3.Enlace a cita original Cita con resumen
The Dry Eye Assessment and Management Study Research Group. n-3 fatty acid supplementation for the treatment of dry eye disease. N Engl J Med 2018;378:3 de mayo. [Ref.ID 102592]
4.Enlace a cita original Cita con resumen
Zong G, Li Y, Wanders AJ, Alssema M, Zock PL, Willett WC, Hu FB, Sun Q. Intake of individual saturated fatty acids and risk of coronary heart disease in US men and women: two prospective longitudinal cohort studies. BMJ 2016;355:i5796. [Ref.ID 100999]
5. Cita con resumen
Wang DD, Li Y, Chiuve SE, Stampfer MJ, Manson JE, Rimm EB, Willett WC, Hu FB. Association of specific dietary fats with total and cause-specific mortality . JAMA Intern Med 2016;176:1134-45. [Ref.ID 100473]
6. Cita con resumen
Hill CL, March LM, Aitken D, Lester SE, Battersby R, Hynes K, Fedorova T, Proudman SM, James M, Cleland LG, Jones G. Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose. Ann Rheum Dis 2016;75:23-9. [Ref.ID 99951]
7. Cita con resumen
Allen K, Pearson-Stuttard J, Hooton W, Diggle P, Capewell S, O’Flaherty M. Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study. BMJ 2015;351:h4583. [Ref.ID 99541]
8. Cita con resumen
Roehr B. Court rules that FDA cannot restrict off-label marketing. BMJ 2015;351:h4367. [Ref.ID 99403]
9. Cita con resumen
Kromhout D. Where the latest US dietary guidelines are heading. BMJ 2015;351:h4034. [Ref.ID 99394]
10. Cita con resumen
Anónimo. Icosapent ethyl (Vascepa) for severe hypertriglyceridemia. Med Lett Drugs Ther 2013;55:33-4. [Ref.ID 95656]
11. Cita con resumen
The Risk and Prevention Study Collaborative Group. N-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med 2013;368:1800-8. [Ref.ID 95534]
12.Tiene citas relacionadas Cita con resumen
Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, Ringel A, Davis JM, Hibbeln JR. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 2013;346:12. [Ref.ID 94928]
13.Tiene citas relacionadas Cita con resumen
Calder PC. American Heart Association advice on omega 6 PUFAs cast into doubt. BMJ 2013;346:8. [Ref.ID 94926]
14.Tiene citas relacionadas Cita con resumen
Chowdhury R, Stevens S, Gorman D, Pan A, Warnakula S, Chowdhury S, Ward H, Johnson L, Crowe F, Hu FB, Franco OH. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ 2012;345:14. [Ref.ID 94003]
15.Tiene citas relacionadas Cita con resumen
de Goede J, Geleijnse JM. The role of fish oils in the prevention of stroke. BMJ 2012;345:9. [Ref.ID 94002]
16. Cita con resumen
Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 2012;308:1024-33. [Ref.ID 93760]
17.Tiene citas relacionadas Cita con resumen
The ORIGIN Trial Investigators. n–3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012;367:309-18. [Ref.ID 92638]
18. Cita con resumen
Palmer DJ, Sullivan T, Gold MS, Prescott SL, Heddle R, Gibson RA, Makrides M. Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ 2012;344:14. [Ref.ID 92405]
19. Cita con resumen
De Caterina R. N-3 fatty acids and cardiovascular disease. N Engl J Med 2011;364:2439-50. [Ref.ID 90939]
20. Cita con resumen
Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S, for the SU.FOL.OM3 Collaborative Group. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 2011;342:36. [Ref.ID 90004]
Seleccionar todas
 
 1 a 20 de 70 siguiente >>